AstraZeneca Loses Battle Against Generic Plendil At Federal Circuit
A U.S. appeals court has ruled that U.K.-Swedish drug maker AstraZeneca can't prevent U.S.-based Mutual Pharmaceutical Co. from selling a generic form of hypertension drug Plendil....To view the full article, register now.
Already a subscriber? Click here to view full article